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Introduction
The autoinflammatory diseases (AID) include mono-
genic and polygenic disorders characterized by primary
dysfunction of the innate immune system.
Objectives
To describe the clinical spectrum, genetic background
and therapy in a cohort of AID patients followed in a
reference Pediatric Rheumatology center.
Methods
Medical records of AID patients followed between May
2007 and November 2010 and entered in the Eurofever
Registry were studied.
Results
Fifty six patients were included: 17 Cryopyrin-Associated
Periodic Syndromes (CAPS), 4 TNF-Receptor-Associated
Periodic fever Syndrome (TRAPS), 5 Hyperimmunoglo-
bulinaemia D with periodic fever Syndrome (HIDS),
18 Familial Mediterranean Fever (FMF), 6 Chronic
Recurrent Multifocal Osteomyelitis (CRMO), 2 Synovitis,
Acne, Pustulosis, Hyperostosis, Osteitis (SAPHO) syn-
drome and 4 Behçet’s Disease (BD). The median follow-
up was 2 years (0-14). The male/female ratio was 20/36.
The median age was 2.5 years at disease onset and 4 at
diagnosis. Family history was positive in 34% of patients.
Clinical manifestations included fever (79%), musculoske-
letal (77%), gastrointestinal (63%), mucocutaneous (61%),
neurological (41%), ocular (34%), cardiorespiratory (13%),
and genitourinary (2%) findings, lymphadenopathy with/
or hepatosplenomegaly (16%) and growth impairment
(25%). Complications/sequelae developed in 45% of
patients. Six patients presented with unusual manifesta-
tions: neonatal peritonitis (1 CAPS), pancreatitis
(1 TRAPS), acute glomerulonephritis (1 FMF), compli-
cated Henoch -Schönlein purpura (1 FMF), peritoneal
adhesions with intestinal occlusion (1 FMF), periorbital
pain (1 CRMO) and cerebral thrombosis (1 BD). AID
was associated with other diseases in 2 patients (FMF/
Henoch-Schönlein purpura and CRMO/enthesitis-related
arthritis). One mutant allele was found in 16/17 CAPS,
4/4 TRAPS and 4/18 FMF patients. Two mutant alleles
were present in 5/5 HIDS and 11/18 FMF patients.
The most used therapeutic agents were biologics (54%)
(Anakinra, Canakinumab, Etanercept, Adalimumab),
NSAIDs (48%), colchicine (45%) and corticosteroids
(29%). Anti-interleukin-1 therapy and colchicine proved
efficacy in CAPS and FMF patients, respectively. In addi-
tion, favorable responses demonstrated anti-interleukin-1
therapy in TRAPS, HIDS and colchicine-resistant FMF
patients, as well as Etanercept in TRAPS, HIDS and
CRMO patients non-responsive to NSAIDs. 57% and
41% of patients were in complete and partial remission,
respectively, at last visit.
Conclusion
AID in children are associated with a broad spectrum of
manifestations. Early diagnosis and referral are essential




1Pediatric Immunology, Hematology and Rheumatology Unit, Necker-Enfants
Malades Hospital, Assistance Publique Hôpitaux de Paris, Paris, France. 2Paris-
Descartes University and IMAGINE Institute, Paris, France. 3Departement of
Pediatric Rheumatology, Gaslini Institute, Genoa, Italy.
Published: 8 November 2013
1Pediatric Immunology, Hematology and Rheumatology Unit, Necker-Enfants
Malades Hospital, Assistance Publique Hôpitaux de Paris, Paris, France
Full list of author information is available at the end of the article
Boiu et al. Pediatric Rheumatology 2013, 11(Suppl 1):A216
http://www.ped-rheum.com/content/11/S1/A216
© 2013 Boiu et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
doi:10.1186/1546-0096-11-S1-A216
Cite this article as: Boiu et al.: P03-018 - Diversity in presenting
manifestations of AUTOINFL. Pediatric Rheumatology 2013
11(Suppl 1):A216.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Boiu et al. Pediatric Rheumatology 2013, 11(Suppl 1):A216
http://www.ped-rheum.com/content/11/S1/A216
Page 2 of 2
